Net profit of Ipca Laboratories rose 31.49% to Rs 326.27 crore in the quarter ended December 2025 as against Rs 248.14 crore during the previous quarter ended December 2024. Sales rose 6.55% to Rs 2392.50 crore in the quarter ended December 2025 as against Rs 2245.37 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 2392.50 | 2245.37 | 7 |
| OPM % | 22.29 | 20.62 | - |
| PBDT | 535.92 | 466.38 | 15 |
| PBT | 428.33 | 367.92 | 16 |
| NP | 326.27 | 248.14 | 31 |